Skip to main content
IBD Pharmacogenetics Group on Muck Rack

IBD Pharmacogenetics Group

As seen in: Wiley, JAMA: Journal of the American Medical Association
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with IBD Pharmacogenetics

Contact IBD Pharmacogenetics, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Root‐cause analyses of missed opportunities for the diagnosis of colorectal cancer in patients with inflammatory bowel disease

|
By Claire Gordon, IBD Pharmacogenetics Group, Desmond Chee, Ben Hamilton
| Color Research & Application Verified
Summary Background Colonoscopic surveillance in patients with inflammatory bowel disease (IBD) leads to earlier detection of colorectal cancer (CRC) and reduces CRC‐associated mortality. However, it is limited by poor adherence in practice. Aim To identify missed opportunities to detect IBD‐associated CRC at our hospital Methods We undertook root‐cause analyses to identify patients with missed opportunities to diagnose IBD‐associated CRC.
Open in Who Shared Issue with article?

Association of Genetic Variants in NUDT15 With Thiopurine-Induced Myelosuppression in Patients With Inflammatory Bowel Disease

|
By Gareth Walker, South Brisbane, IBD Pharmacogenetics Group
| JAMA: Journal of the American Medical Association Verified
[Skip to Content Landing] Original Investigation February 26, 2019 JAMA. 2019;321(8):773-785.
Open in Who Shared Issue with article?
See all 2 articles